| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Colistimethate sodium |
| Brand | Colobreathe® |
| Indication | For the management of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis (CF) aged 6 years and older. |
| Assessment Process | |
| Rapid review commissioned | 07/06/2013 |
| Rapid review completed | 28/06/2013 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |